Literature DB >> 22989101

Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma.

Tomoya Kon1, Fumiaki Mori, Kunikazu Tanji, Yasuo Miki, Tamaki Kimura, Koichi Wakabayashi.   

Abstract

We describe an unusual case of myasthenia gravis. Our patient had been diagnosed as having myasthenia gravis with thymoma at the age of 64 years, and died of acute respiratory failure at the age of 80 years. Post mortem examination revealed CD8-positive lymphocytic infiltration with numerous giant cells in the skeletal muscles and myocardium. Immunohistochemical and ultrastructural studies revealed that there were two types of giant cells: histiocytic and myocytic in origin. Furthermore, both types of giant cells were immunopositive for proteins implicated in the late endosome and lysosome-protease systems, suggesting that endocytosis may be the key mechanism in the formation of giant cells. The present case, together with a few similar cases reported previously, may represent a particular subset of polymyositis, that is, giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma.
© 2012 Japanese Society of Neuropathology.

Entities:  

Mesh:

Year:  2012        PMID: 22989101     DOI: 10.1111/j.1440-1789.2012.01345.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  11 in total

Review 1.  Paraneoplastic disorders in thymoma patients.

Authors:  Amelia Evoli; Eric Lancaster
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

2.  Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series.

Authors:  Puja Arora; Laura Talamo; Patrick Dillon; Ryan D Gentzler; Trish Millard; Michael Salerno; Craig L Slingluff; Elizabeth M Gaughan
Journal:  Cardiooncology       Date:  2020-09-23

Review 3.  Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature.

Authors:  Frank A Scangarello; Luisa Angel-Buitrago; Melanie Lang-Orsini; Alexander Geevarghese; Knarik Arkun; Oscar Soto; Mithila Vullaganti; Robert Kalish
Journal:  Clin Rheumatol       Date:  2021-02-25       Impact factor: 2.980

4.  Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome.

Authors:  Stéphane Mathis; Laurent Magy; Philippe Corcia; Karima Ghorab; Laurence Richard; Jonathan Ciron; Mathilde Duchesne; Jean-Michel Vallat
Journal:  Case Rep Neurol Med       Date:  2016-12-01

5.  Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk?

Authors:  Chen Zhao; Arun Rajan
Journal:  Mediastinum       Date:  2019-09-09

6.  Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology.

Authors:  Naohiro Uchio; Kenichiro Taira; Chiseko Ikenaga; Masato Kadoya; Atsushi Unuma; Kenji Yoshida; Setsu Nakatani-Enomoto; Yuki Hatanaka; Yasuhisa Sakurai; Yasushi Shiio; Kenichi Kaida; Akatsuki Kubota; Tatsushi Toda; Jun Shimizu
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-12-24

7.  Giant cell myositis and myocarditis revisited.

Authors:  Piraye Oflazer
Journal:  Acta Myol       Date:  2020-12-01

8.  Thymoma may explain the confusion: a case report.

Authors:  Abdelkhaleq Maaroufi; Naoufal Assoufi; Mohamed Amine Essaoudi; Jamal Fatihi
Journal:  J Med Case Rep       Date:  2021-12-16

9.  An Overview of Cardiac Management in Neuromuscular Disease.

Authors:  Renee M Hickey; John D Cullen; George M Sachs
Journal:  Open Cardiovasc Med J       Date:  2016-05-27

Review 10.  An overview on the differential diagnostics of tumors of the anterior-superior mediastinum: the pathologist's perspective.

Authors:  Mirella Marino; Stefano Ascani
Journal:  Mediastinum       Date:  2019-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.